Top Markets
#1 Palladium Network Palladium Network +27.94%
#2 MarsCoin MarsCoin +25.78%
#3 Hive Hive +25.60%
#4 Siren Siren +24.48%
#5 BankrCoin BankrCoin +20.74%
#6 Ankr Network Ankr Network +17.93%
#7 StonkBroker StonkBroker +16.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
#9 Status Status +11.03%
#10 Provenance Blockchain Provenance Blockchain +8.81%
Coin of the day
Palladium Network Palladium Network
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited

TaiGen Biopharmaceuticals Holdings Limited

4157
Classifica tra le azioni #18382
TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm... TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm dedicated to pioneering innovative treatments for life-altering diseases. Its robust development pipeline features several key assets. Among these is Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic currently being advanced for the treatment of various bacterial infections, including community-acquired pneumonia and diabetic foot infections. The company is also progressing Burixafor, a stem cell mobilizer with applications in stem cell transplantation and chemosensitization. Further contributing to its portfolio is TG-1000, an antiviral medication designed to combat influenza A, B, and the avian influenza H7N9 strain. Additionally, Furaprevir, a hepatitis C virus (HCV) protease inhibitor, is under development for managing chronic hepatitis C. Established in 2001, TaiGen Biopharmaceuticals maintains its headquarters in Taipei City, Taiwan.
Prezzo delle azioni
$0.28237537
Capitalizzazione di mercato
$201.00M
Variazione (1 giorno)
0.23%
Variazione (1 anno)
-9.68%
Paese
TW
Scambia TaiGen Biopharmaceuticals Holdings Limited (4157)

Categoria

Healthcare
Il prezzo 4157 con la capitalizzazione del mercato della B
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
4157
$0.28237537
Capitalizzazione di mercato di TaiGen Biopharmaceuticals Holdings Limited(4157)
Capitalizzazione di mercato: $201.00M
A partire dal September 2026, TaiGen Biopharmaceuticals Holdings Limited ha una capitalizzazione di mercato pari a $201.00M. Questo rende TaiGen Biopharmaceuticals Holdings Limited la 18382nd azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di TaiGen Biopharmaceuticals Holdings Limited dal 2013 al 2026
4157 in paragone con la classifica dei più popolari stocks
Il prezzo per 4157 Attivo B Capitalizzazione del mercato a B Risultati
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$7,620.17 $201.00M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.424T +2,698,494.30%
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$6,709.27 $201.00M
Apple Inc. Apple Inc.
AAPL
$4.776T +2,375,911.59%
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$5,692.08 $201.00M
Alphabet Inc. Alphabet Inc.
GOOG
$4.052T +2,015,683.73%
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$5,185.25 $201.00M
Microsoft Corporation Microsoft Corporation
MSFT
$3.691T +1,836,197.69%
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$3,855.17 $201.00M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.744T +1,365,165.61%